← Health care and life sciences companies

    AC Immune: company profile, size and contacts

    acimmune.comActiveFor profit

    AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials

    Employees
    51-100
    Founded
    2003
    Total raised
    $167.5M
    Monthly visits
    3,538

    Company facts

    Website
    acimmune.com
    Location
    Europe, Middle East, and Africa (EMEA)
    Employees
    51-100
    Founded
    2003 (23 years ago)
    Categories
    Biotechnology, Pharmaceutical, Therapeutics
    Company type
    For profit
    Listing
    Public (NASDAQ:ACIU)
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Andrea PfeiferFounder · AC Immune

    AC Immune was founded in 2003 by Andrea Pfeifer.

    Funding

    Total raised
    $167.5M
    Funding rounds
    5
    Latest round
    Post ipo equity, 2023-12
    Investors
    6
    Lead investors
    3

    Web and app presence

    Monthly website visits
    3,538
    Global traffic rank
    #3,607,302

    How AC Immune compares

    • Size: AC Immune has more employees than 56% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: AC Immune is older than 56% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: AC Immune gets more monthly website visits than 62% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 159 of them in the same 51-100 employee range and 131 based in Europe.

    Growth outlook

    • Trend: Stable
    • Direction: Stable
    • Confidence: Low

    Takeda has entered into a $2.2 billion deal with AC Immune for an Alzheimer's therapy. Individual investors own 24% of AC Immune shares, while private equity firms control 30% of the company.

    What AC Immune says about itself

    “AC Immune SA, a global leader in developing precision medicine for neurodegenerative diseases (incl. Alzheimer & Parkinson's) with cutting-edge technology platforms” acimmune.com

    AC Immune in short

    Founded in 2003, AC Immune works in biotechnology, pharmaceutical and therapeutics from Europe and has 51-100 employees. It has raised $167.5 million over 5 rounds and its website drew about 3,538 visits in the latest month measured.

    Frequently asked questions

    What does AC Immune do?
    AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials
    When was AC Immune founded?
    AC Immune was founded in 2003, so it is about 23 years old.
    How many employees does AC Immune have?
    Crunchbase lists AC Immune in the 51-100 employee range.
    Where is AC Immune based?
    AC Immune is listed under Europe, Middle East, and Africa (EMEA).
    Has AC Immune raised funding?
    Crunchbase records $167.5M raised across 5 funding rounds, most recently post ipo equity in 2023-12.
    How do I find email addresses at AC Immune?
    Search the domain acimmune.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.